InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Richard Buick. Director active across 1 company, notably Fusion Antibodies plc. Aggregated, 2 disclosures have been published. History available since 9 June 2023. The latest transaction was filed on 9 September 2024 (Purchase). Regulator: RNS (LSE). All data is accessible without signup.
2 of 2 declarations